• News & Events
  • Resources
  • Careers
  • Investors
Aptar Logo
  • Products
  • business areas
  • Services
  • ESG
  • About Aptar
Pharmaceutical, Publications

USP <382> System-Level Insights for Earlier Primary Packaging Decisions

19 Oct 2026

USP <382> is an important compliance milestone for injectable packaging and delivery systems, but related system-level data can also support earlier development decisions. This article from Aptar Pharma explains how comparative testing across configurations, materials, liquid properties and conditioning conditions can help teams interpret system behaviour, identify potential sensitivities and focus subsequent development work, without replacing final product-specific testing.

By Pavan Hemmege Venkatappa
$resourceAuthor.title
Share
ONdrugDel-PFS-Oct2026-Aptar (1).jpg

Learn more about Aptar Pharma Expertise
in Injectable Drug Delivery

 

Find Out More About Injectable Drug Delivery

This Might Also Be of Interest

27 Oct 2026
Injectable Drug Packaging: Why Component Quality Matters

Pharmaceutical Webinars
19 Oct 2026
USP <382> System-Level Insights for Earlier Primary Packaging Decisions

Pharmaceutical Publications
29 Sep 2026
Where Does Your Contamination Control Strategy Really End?

Pharmaceutical Blogs
22 Sep 2026
The Elastomeric Stopper as Part of a System: Considerations Under USP <382>

Pharmaceutical Publications